Plus, a precision medicine company betting on human genetics....
Plus, a Top 1% analyst's Street-high edge-AI call...
Plus, the largest US gas producer at a peer discount...
Plus, a surprising med-tech name riding the GLP-1 boom...
One stock pick from a top-ranked analyst with an implied upside of 100% or more.
September is historically the market's worst month. Here's where the money may be hiding.
Plus, a cancer-imaging play with a looming FDA date... and a whopping 95% implied upside.
Plus, the year’s biggest chip IPO still has plenty of room to run...
Plus, a Street-high target on a lagging tech giant...
Plus, Wall Street's highest target on a major data platform...
Plus, a lidar leader riding the humanoid robot wave...
Plus, a Bitcoin miner is pivoting to AI data centers with 99% potential upside...
Plus, a human-first tech company a top analyst calls AI-proof...
Plus, an AI-powered drugmaker's hair loss breakthrough...
